- Ostro, headquartered in Miami, Florida, is a leading brand engagement platform for life sciences, specializing in AI-powered conversational tools that facilitate real-time communication between pharma companies, doctors, and patients.
- In March 2026, Ostro was acquired by Veeva Systems for approximately $100 million, allowing it to operate as an independent unit while integrating its technology with Veeva's Commercial Cloud.
- Ostro's tools are utilized by various pharmaceutical companies to enhance patient engagement and streamline access to compliant medical information, significantly improving the user experience for both healthcare providers and patients.
- Ostro's ideal buyers are pharmaceutical companies seeking to improve their engagement strategies; they address the pain point of inefficient communication by providing instant, compliant answers through an easy-to-use AI-driven chat experience.
Ostro's workforce is organized into 11 departments, with a total headcount of 200 employees. The largest departments are Operations, with 6 employees, and Health Services and Information Technology, each with 3 employees. This distribution indicates a balanced focus on operational efficiency and technical support, while also maintaining essential services. The presence of smaller teams in Sales, Engineering, and other functional areas suggests a lean organizational structure that can adapt to project demands.
Ostro operates across 15 locations, with a notable presence in major cities such as New York, NY, and San Francisco, CA, each housing 2 employees. The geographic distribution reflects a predominantly remote or distributed workforce, as the 'Other' category accounts for 11 additional locations. This pattern indicates a strategic approach to talent acquisition, allowing the company to tap into diverse markets while maintaining a centralized headquarters in Miami, Florida.
